Effects of acadesine on myocardial infarction, stroke, and death following surgery: A meta-analysis of the 5 international randomized trials

JAMA

Volumn 277, Issue 4, 1997, Pages 325-332

  Mangano, Dennis T ^a,b,c,d  

^a C AND EN   (United States)

^b Multicenter Stud Perioprative I   (Canada)

^c Ischemia Research and Education Foundation   (United States)

^d 250 Executive Park Blvd   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE; CARDIOPLEGIC AGENT; PURINE NUCLEOSIDE;

ADULT; AGED; CARDIOPLEGIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; STROKE; SURGICAL MORTALITY; TREATMENT OUTCOME;

EID: 0031021506     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.277.4.325     Document Type: Review

References (54)

1. Mangano DT. Perioperative cardiac morbidity. Anesthesiology. 1990;72:153-184.
2. US Public Health Service. Mortality, part A. Vital Health Stat 2. 1985;2:10-17, 67-68, 100-101.
3. Kouchoukos NT, Ebert PA, Grover FL, Lindesmith GG. Report of the ad hoc committee on risk factors for coronary artery bypass surgery. Ann Thorac Surg. 1988;45:348-349.
4. CASS Principal Investigators and Their Associates. Myocardial infarction and mortality in the Coronary Artery Surgery Study (CASS) randomized trial. N Engl J Med. 1984;310:750-758.
5. Murphy ML, Hultgren HN, Detre K, Thomsen J, Takaro T, for the Participants of the Veterans Administration Cooperative Study. Treatment of chronic stable angina: a preliminary report of survival data of the randomized Veterans Administration Cooperative Study. N Engl J Med. 1977; 297:621-627.
6. Varnauskas E. European coronary surgery study. Z Kardiol. 1985;6:73-78.
7. Mangano DT. Perioperative cardiac morbidity: epidemiology, costs, problems, and solutions. West J Med. 1994;161:87-89.
8. Mangano DT. Myocardial stunning: an overview. J Cardiac Surg. 1993;8:204-213.
9. Gruber HE, Hoffer ME, McAllister DR, et al. Increased adenosine concentration in blood from ischemic myocardium by AICA riboside: effects on flow, granulocytes, and injury. Circulation. 1989; 80:1400-1411.
10. Mullane K. The prototype adenosine regulating agent for reducing myocardial ischemic injury. Cardiovasc Res. 1993;27:43-47.
11. Leung JL, Stanley T, Mathew J, for the McSpi Research Group. Initial multicenter randomized controlled trial on the safety and efficacy of acadesine in patients undergoing CABG surgery. Anesth Analg. 1994;78:420-434.
12. Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM, for the McSPI Research Group. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. N Engl J Med. 1990;323:1781-1788.
13. Menasché P, Jamieson WRE, Flameng E, Davies M, on behalf of the Multinational Aeadesine Study Group, Aeadesine: a new drug that may improve myocardial protection in coronary artery bypass graft surgery: results of the first international multicenter study. J Thorac Cardiovasc Surg. 1995;110:1096-1106.
14. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Effects of acadesine on morbidity and mortality following coronary artery bypass graft surgery. Anesthesiology. 1995; 83:658-673.
15. Mangano DT, for the McSPI Research Group. Effects of acadesine on myocardial infarction, stroke, and death following surgery. Anesth Analg. 1996; 82:SCA42.
16. Demeyere RH, Van Kerrebroeck CJ, Flameng WJ. Cardioprotective effects of acadesine in patients with unstable angina undergoing aortocoronary bypass surgery. Circulation. 1994;90(4, pt 2):I-370.
17. Oxman AD, Clarke MJ, Stewart LA. From science to practice: meta-analyses using individual patient data are needed. JAMA. 1995;274:845-846.
18. Jeng GT, Scott JR, Burmeister LF. A comparison of meta-analytic results using literature vs individual patient data: paternal cell immunization for recurrent miscarriage. JAMA. 1995;274:830-836.
19. Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med. 1991;10:1665-1677.
20. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335-371.
21. Department of Applied Statistics. PEST 3.0: Planning and Evaluation of Sequential Trials. Reading, United Kingdom: University of Reading; 1993.
22. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: John Wiley & Sons Inc; 1980.
23. Jones EL, Weintraub WS, Craver JM, Guyton RA, Cohen CL. Coronary bypass surgery: is the operation different today? J Thorac Cardiovasc Surg. 1991;101:108-115.
24. Haraphongse M, Na-Ayudhya RK, Teo KK, et al. The chanuging clinical profile of coronary artery bypass graft patients, 1970-1989. Can J Cordial. 1994;10:71-86.
25. Clark RE. Calculating risk and outcome: the Society of Thoracic Surgeons database. Ann Thorac Surg. 1996;62:S2-5.
26. Jain U, Zhang A, Sears RJ, Titov V, Titov T, for the McSPI Research Group. Incidence of Q wave myocardial infarction during coronary artery bypass graft surgery in the 24-center McSPI population. Anesthesiology. 1994;81:A157.
27. Aggarwal A, Jain U, Ramsay JG, Wilson R, Comunale ME, for the McSPI Research Group. CK-MB release after coronary artery bypass graft surgery in a multicenter population. Anesthesiology. 1994;81: A1291.
28. Mora CT, Murkin JM. The central nervous system: responses to cardiopulmonary bypass. In: Mora CT, ed. Cardiopulmonary Bypass: Principles and Techniques of Extracorporeal Circulation. New York, NY: Springer-Verlag NY Inc; 1995:114-146.
29. The Warm Heart Investigators. Randomised trial of normothermic versus hypothermic coronary bypass surgery. Lancet. 1994;343:559-563.
30. Martin TC, Craver JM, Gott JP, et al. Prospective, randomized trial of retrograde warm-blood cardioplegia: myocardial benefit and neurologic threat. Ann Thorac Surg. 1994;57:298-304.
31. Rashid A, Fabri BM, Fabri BM, et al. A prospective randomised study of continuous warm versus intermittent cold blood cardioplegia for coronary artery surgery: preliminary report. Eur J Cardiothorac Surg. 1994;8:265-269.
32. Ely SW, Berne RM. Protective effects of adenosine in myoeardial ischemia. Circulation. 1992;85: 893-904.
33. Mullane K, Young M. Acadesine: prototype adenosine regulating agent for treating myocardial ischemia-reperfusion injury. Drug Des Res. 1993; 28:336-343.
34. Ambrosio G, Jacobus W, Mitehell M, Litt M, Becker L. Effects of ATP precursors on ATP and free ADP content and functional recovery of postischemic hearts. Am J Physiol. 1989;256:H560-H566.
35. Mentzer R, Ely S, Lasley R, Berne R. The acute effects of AICAR on purine nueleotide metabolism and postischemic cardiac function. J Thorac Cardiovas Surg. 1988;95:286-293.
36. Vinten-Johansen J, Nakanishi K, Zhao ZQ, McGee DS, Tan P. Acadesine improves surgical myocardial protection with blood cardioplegia in isehemically injured canine hearts. Circulation. 1993; 88:350-358.
37. Galiñanes M, Bullough D, Mullane KM, Hearse DJ. Sustained protection by acadesine against ischemia and reperfusion-induced injury: studies in the transplanted rat heart. Circulation. 1992;86:589-597.
38. Lachin J. Sample size determination for rxc comparative trials. Biometrics. 1977;331:315-324.
39. Young M, Mullane K. Progressive cardiac dysfunction with repeated pacing-induced ischemia: protection by AICA-riboside. Am J Physiol. 1991; 261:H1570-H1577.
40. Mazur C, Mullane K, Young MA. Acadesine preserves cardiac function and enhances coronary blood flow in isolated, blood perfused rabbit hearts with repeated ischemia and reperfusion. J Mol Cell Cardiol. 1991;23:S45.
41. Molina-Viamonte V, Rosen MR. AICA-riboside supresses arrhythmias induced by coronary artery occlusion and reperfusion. Circulation. 1990;82:645.
42. Henry C, Young M, Zhang C, Bullough D, Muliane K. Adenosine release from red cells mediates inhibition of platelet aggregation by acadesine and delays post-thrombolytic reoeelusion in dogs. Circ Suppl. 1991;84:247.
43. Young M, Montag A, Zhang C, Bullough D, Mullane K. Inhibition of intracoronary thrombosis by acadesine: an adenosine-mediated, erythrocyte-dependent activity. Eur Heart J. 1993;31:14.
44. Cronstein BN, Eberle MA, Gruber HE, Levin RI. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci U S A. 1991;88:2441-2445.
45. Galiñanes M, Mullane KM, Bullough D, Hearse DJ. Acadesine and myocardial protection: studies of time of administration and dose-response relations in the rat. Circulation. 1992;86:598-608.
46. Val PG, Pelletier LC, Hernandez MG, et al. Diagnostic criteria and prognosis of perioperative myocardial infarction following coronary bypass. J Thorac Cardiovasc Surg. 1983;86:878-886.
47. Schaff HV, Gersh BJ, Fisher LD, et al. Detrimental effect of perioperative myocardial infarction on late survival after coronary artery bypass: report from the Coronary Artery Surgery Study (CASS). J Thorac Cardiovasc Surg. 1984;88:972-981.
48. Thacker SB. Meta-analysis: a quantitative approach to research integration. JAMA. 1988;259: 1685-1689.
49. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
50. Lau J, Antman EM, Jiminez-Silva J, Kupelnick B, Mosteller F, Chalmvers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med. 1992;327:248-254.
51. Egger M, Smith GD. Misleading meta-analysis: lessons from 'an effective, safe, simple' intervention that wasn't. BMJ. 1995;310:752-754.
52. Antman EM, Lau J, Kupeinick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts: treatments for myocardial infarction. JAMA. 1992;268:240-248.
53. Gotzsche PC. Reference bias in reports of drug trials. BMJ. 1987;95:654-656.
54. Yusuf S, Flather M. Magnesium in acute myocardial infarction. BMJ. 1995;310:751-752.